Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1998
-
Total 13F shares, excl. options
-
1.07B
-
Shares change
-
+31.5M
-
Total reported value, excl. options
-
$119B
-
Value change
-
+$3.49B
-
Put/Call ratio
-
0.74
-
Number of buys
-
992
-
Number of sells
-
-876
-
Price
-
$110.87
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2025
2,236 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2025.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,998 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07B shares
of 1.24B outstanding shares and own 86.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (119M shares), BlackRock, Inc. (115M shares), FMR LLC (60M shares), STATE STREET CORP (59.2M shares), Capital World Investors (46.3M shares), WELLINGTON MANAGEMENT GROUP LLP (37.5M shares), Capital Research Global Investors (31.1M shares), Dodge & Cox (30.8M shares), GEODE CAPITAL MANAGEMENT, LLC (29.2M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (23.6M shares).
This table shows the top 1998 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.